Search research articles
Contact Us
Filters
Showing results (51-60 of 132) with videos related to
Page
of 14
Sort By:
Drugs & Aging
|
October 26, 2005
Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease
Stephen L Archer, Ferrante S Gragasin, Linda Webster, et al.
Circulation Research
|
May 9, 2013
Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension
Peter Dromparis, Roxane Paulin, Gopinath Sutendra, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 11, 2014
Pioglitazone inhibits HIF-1α-dependent angiogenesis in rats by paracrine and direct effects on endothelial cells
Peter Dromparis, Gopinath Sutendra, Roxane Paulin, et al.
Circulation
|
November 15, 2012
Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension
Peter Dromparis, Roxane Paulin, Trevor H Stenson, et al.
Biological Chemistry
|
May 12, 2004
O2 sensing in the human ductus arteriosus: redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide
Stephen L Archer, Xi-Chen Wu, Bernard Thébaud, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
August 7, 2007
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study
M Sean McMurtry, Sebastien Bonnet, Evangelos D Michelakis, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
December 5, 2006
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
M Sean McMurtry, Rohit Moudgil, Kyoko Hashimoto, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
July 13, 2013
A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension
Gopinath Sutendra, Peter Dromparis, Roxane Paulin, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 22, 2002
Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition
Václav Hampl, Jana Bíbová, Zbynek Stranák, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 3, 2011
Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension
Gopinath Sutendra, Peter Dromparis, Sébastien Bonnet, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 132) with videos related to
Sort By:
Page
of 14
Drugs & Aging
|
October 26, 2005
Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease
Stephen L Archer, Ferrante S Gragasin, Linda Webster, et al.
Circulation Research
|
May 9, 2013
Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension
Peter Dromparis, Roxane Paulin, Gopinath Sutendra, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 11, 2014
Pioglitazone inhibits HIF-1α-dependent angiogenesis in rats by paracrine and direct effects on endothelial cells
Peter Dromparis, Gopinath Sutendra, Roxane Paulin, et al.
Circulation
|
November 15, 2012
Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension
Peter Dromparis, Roxane Paulin, Trevor H Stenson, et al.
Biological Chemistry
|
May 12, 2004
O2 sensing in the human ductus arteriosus: redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide
Stephen L Archer, Xi-Chen Wu, Bernard Thébaud, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
August 7, 2007
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study
M Sean McMurtry, Sebastien Bonnet, Evangelos D Michelakis, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
December 5, 2006
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
M Sean McMurtry, Rohit Moudgil, Kyoko Hashimoto, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
July 13, 2013
A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension
Gopinath Sutendra, Peter Dromparis, Roxane Paulin, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 22, 2002
Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition
Václav Hampl, Jana Bíbová, Zbynek Stranák, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 3, 2011
Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension
Gopinath Sutendra, Peter Dromparis, Sébastien Bonnet, et al.
Page
of 14